Lung cancer is currently the malignant tumor with the highest incidence and mortality in the
world, while non-small cell lung cancer (NSCLC) is the most common pathological type of …

Immune checkpoint inhibitors have become the standard of care in the treatment of
metastatic non-small-cell lung cancer (NSCLC). The combination of nivolumab plus …

Due to extremely poor prognosis, pancreatic cancer (PDAC) represents the fourth leading
cause of cancer-related death in Western countries. For more than a decade, gemcitabine …

Lung cancer (LC), particularly nonsmall cell lung cancer (NSCLC), is one of the most
prevalent types of neoplasia worldwide, regardless of gender, with the highest mortality …

Background We applied mathematical models to clinical trial data available at Project Data
Sphere LLC (Cary, NC, USA), a non-profit universal access data-sharing warehouse. Our …

Background/Aims: Recurrent gene mutation has been identified by the analysis of exonic
DNA from lung adenocarcinoma, but its progression has not been extensively profiled. The …

Despite the progress in the comprehension of LC progression, risk, immunologic control,
and treatment choices, it is still the primary cause of cancer-related death. LC cells possess …

We aimed to explore the possible mechanism of microRNA-196a (miR-196a) inhibition and
reversion of drug resistance to cisplatin (DDP) of the A549/DDP non-small-cell lung cancer …

Lung cancer is one of the most common malignant tumor types and the leading cause of
cancer-associated death worldwide. Different types of lung cancer exhibit differences in …

Background Patients with N3 stage nasopharyngeal carcinoma (NPC) are at high risk for
treatment failure. This study aims to assess the efficacy of maintenance chemotherapy (MC) …